A novel scoring system for precise severity quantification in severe fever with thrombocytopenia syndrome: development and application based on dynamic clinical data.

In the progressive phase (days 5–7), multiple indicators presented intergroup differences (all p < 0.05), among which age, PLT, AST, and Cr exhibited extremely significant differences ( p < 0.001); the non-survivor group was characterized by older age, elevated AST and Cr, and reduced PLT.

also in 5,999 other papers